Filter
275
Filtered Results: 275
Text search:
anticuerpos
Featured
Recommendations
15
New Publications
89
Language
Document type
Guidelines
131
No document type
87
Manuals
20
Studies & Reports
17
Fact sheets
10
Strategic & Response Plan
8
Training Material
1
Resource Platforms
1
Countries / Regions
Brazil
48
Argentina
30
Latin America and the Carribbean
26
Paraguay
24
Colombia
23
Bolivia
15
Mozambique
14
Venezuela
13
Ecuador
10
Peru
8
Angola
8
Chile
7
Spain
5
El Salvador
4
Guinea-Bissau
4
Global
2
Dominican Republic
2
Mexico
1
Africa
1
Germany
1
North America
1
Portugal
1
Nicaragua
1
Honduras
1
Cuba
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Guidelines
101
COVID-19
100
Policies & Guidelines HIV & TB
29
Studies & Reports
12
Women & Child Health
9
Chagas
7
Policies
6
Drugs & Medical Equipment
5
Virology
4
Yellow Fever
4
Immunization
4
Information, Education and Communication (IEC)
3
Leishmaniasis
3
Communicable Diseases
2
Hepatitis
2
Bacteriology
2
Vaccine-preventable Diseases
2
Capacity Building
2
Statistics
2
Parasitology
2
HIV & STI
2
Dental & Eye Care
1
Disaster Preparedness
1
General Guidelines
1
Vector Control
1
Breast Cancer
1
Pediatrics
1
Clinical Guidelines
1
Demograhic Health Surveys DHS
1
Humanitarian Crisis
1
Other
1
General Guidelines
1
Women & Child Health
1
Maternal Health
1
Dengue
1
Malaria
1
Disease Prevention & Control
1
Toolboxes
Country specific documents
79
Clinical Guidelines
22
Diagnostics & Laboratory Guidance
10
IACAPAP International Association for Child and Adolescent Psychiatry and Allied Professions
5
Children/Adolescents Mental Disorders
5
Infection Control General
5
Surveillance & Contact tracing
5
Biontech/Pfizer Comirnaty
4
Laboratory & Diagnostics
4
Gynaecology / Obstetrics
3
Yellow Fever Prevention & Control
3
Paediatrics
3
Physical Distancing
3
Communication Material
3
Immunization Guidelines
3
Moderna
3
Inactivated COVID-19 Vaccines
3
Essential Medicines & Devices Lists
3
National Emergency Response Plans
3
TB/HIV Coinfection
3
Chikungunya Prevention & Control
3
Health Systems
2
Laboratory Guidance
2
Dengue
2
Public Health
2
Context & Facts
2
Context & Facts, Travel Advice
2
COVID-19
2
For Pregnant Women
2
For Health Worker
2
Workplace
2
Genomic sequencing
2
SARS-CoV-2 Variants
2
Vaccine Hesitancy & Myths
2
Vaxzevria (Astra Zeneca)
2
Colombia
2
Chile
2
Other Countries
2
Clinical Aspects & Diagnostics
2
Clinical Guidelines
2
Postexposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
2
Zika
2
Yellow Fever Situation Report
2
Paediatrics
2
Drugs
1
Outbreak Prevention & Control
1
Treatment Guidelines
1
TB & Drug Abuse
1
HIV testing & services
1
Clinical Aspects, Treatment & Prevention
1
Yellow Fever
1
Prevention & Control
1
Children & Adolescents
1
Surveillance
1
Men who have sex with men (MSM)
1
Latin America
1
Cholera
1
General
1
Prevention & Preparedness
1
For General Public & Community
1
Human Rights
1
Information for the Public
1
Educational Settings
1
LGBTI*
1
HIV and COVID-19
1
COVID-19
1
Infection Control & Prevention (IPC)
1
Essential Medicines & Medical Devices
1
Hospital Readiness/Essential Health Services
1
Blood Supply
1
Mythbusters/Misinformation
1
Tips & Best Practice Examples
1
Non-pharmaceutical interventions (NPIs)
1
TB/COVID-19
1
Vector-based Vacines General
1
Johnson & Johnson
1
Covaxin
1
Research & Pipeline
1
Others
1
Primary Care
1
Community Health Workers CHW
1
Nurses
1
Latin America
1
Booster Doses
1
Planetary Health
1
Clean air
1
Argentina
1
Pharmacovigilance
1
Capacity Building & Resources
1
Clinical Aspects & Diagnostics
1
Information & Education Material (IEC)
1
Studies & Reports
1
Detection & Diagnosis
1
Autism
1
Contact Tracing
1
Alzheimer's Disease & Dementia
1
Prevention of Disabilites
1
Research & Access
1
Latin America & the Carribean
1
Testing Guidelines
1
Zika Prevention & Control
1
Antiretroviral Treatment ART
1
HIV in Key Populations
1
Chikungunya
1
Case Definitions
1
Cyclones Idai & Kenneth
1
Evaluation of the effectiveness of vaccines against COVID-19
INTERIM GUIDANCE 17 MARCH 2021
Definition and categorization of the time of vertical transmission of SARS-CoV-2
Scientific report 8 February 2021
Considerations on the implementation and adjustment of
public health and social measures in the context of
COVID-19
Interim guidance 14 June 2021
Strengthening surveillance for Variant of Concern (VOC) Omicron (B.1.1.529): technical brief and priority actions for member states World Health Organization Headquarters, 28 November 2021
Instructional Manual for the care of pregnant and postpartum women in the context of the covid-19 pandemic
Este Manual de Recomendações para a Assistência à Gestante e Puérpera visa orientar o acesso e a horizontalidade da assistência durante a pandemia Covid-19, abordando as vias de transmis...
Covid-19 Epidemiological Surveillance Guide: Public Health Emergency of National Importance for Coronavirus Disease 2019 - version 4
Practical Guide to Occupational Health Management for Covid-19
A Associação Nacional de Medicina do Trabalho – ANAMT e a Secretaria de Gestão do Trabalho e da Educação em Saúde – SGETS/MS, considerando as ações governamentais das instâncias federal, estadual, distrital e municipal para...
The social impacts of Covid-19 in Brazil: vulnerable populations and responses to the pandemic
Passados os primeiros meses da pandemia do novo coronavírus no Brasil, o Observatório Covid-19 Fiocruz, em parceria com a Editora Fiocruz e com o apoio da Rede SciELO Livros, traz para o público leitor...
O Informe Semanal de Evidências sobre Variantes de Atenção do SARS-CoV-2 é uma produção organizada pelo Departamento de Ciência e Tecnologia da Secretaria de Ciência, Tecnologia, Inovação e Insumos Estratégicos em Saúde do Ministério da Saúde (DECIT/SCTIE/MS). O documento tem o objetiv...
As vacinas COVID-19 são eficazes contra novas variantes? O que significa para uma pessoa estar totalmente vacinada? Essa e outras dúvidas estão entre as dúvidas mais frequentes sobre a vacinação contra a COVID-19. Nesta sexta edição você encontrará respostas para essas e outras perguntas.
...
Este instructivo se aplica a la implementación del SNVS 2.0 para la notificación de pruebas rápidas para sífilis, vih y/o hepatitis b y c; en los puntos de atención para personas usuarias del sistema de salud. Éstos pueden ser centros de salud del primer nivel de atención, locales o espacios ...
Este documento de consenso brinda herramientas a los equipos de salud para acompañar modificaciones corporales vinculadas a procesos de construcción identitaria de niñeces y adolescencias trans, travestis y no binarias desde una mirada integral, basadas en la evidencia científica disponible, con...
A erradicação da varíola humana (mpox em inglês) foi certificada em 1980. A varíola símia (mpox em inglês) é endêmica nos países da África Central e Ocidental desde a sua primeira detecção, em 1958. Trata-se de uma zoonose cujos casos geralmente ocorrem perto de florestas tropicais, ond...
